Baker Bros. Advisors LP

Baker Bros. Advisors LP reported 80 holdings worth US$21B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Baker Bros. Advisors LP reported 80 holdings worth US$21B as of Sep 30, 2026. Largest: Incyte Corporation, BeOne Medicines Ltd. Class A and Revolution Medicines, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
80
Value as reported
US$21B

The filing in full

CompanySharesValue as reported% of portfolio
Incyte Corporation30.8MUS$3.73B17.7%
BeOne Medicines Ltd. Class A8.83MUS$3.23B15.4%
Revolution Medicines, Inc.10.6MUS$2.18B10.4%
Kodiak Sciences Inc21.9MUS$2.07B9.8%
Madrigal Pharmaceuticals, Inc.2.14MUS$1.08B5.1%
Insmed Incorporated8.8MUS$1B4.8%
Kymera Therapeutics, Inc.8.66MUS$968M4.6%
ACADIA Pharmaceuticals Inc.42.9MUS$865M4.1%
GRAIL, Inc.4.03MUS$564M2.7%
Summit Therapeutics Inc.32.8MUS$554M2.6%
Rhythm Pharmaceuticals, Inc.5.6MUS$534M2.5%
Praxis Precision Medicines, Inc.1.75MUS$511M2.4%
AbCellera Biologics Inc.33MUS$482M2.3%
Celcuity Inc.4.82MUS$383M1.8%
IDEAYA Biosciences, Inc.5.01MUS$192M0.91%
Edgewise Therapeutics, Inc.3.7MUS$150M0.71%
Replimune Group, Inc.11MUS$146M0.69%
Roivant Sciences Ltd.3.66MUS$134M0.64%
Arrowhead Pharmaceuticals, Inc.1.71MUS$112M0.53%
Nurix Therapeutics, Inc.4.66MUS$110M0.52%
Immunovant, Inc.2.77MUS$93.6M0.44%
Celldex Therapeutics, Inc.2.56MUS$83.1M0.40%
Denali Therapeutics Inc.3.73MUS$77.2M0.37%
Dianthus Therapeutics, Inc.852KUS$75M0.36%
Rapport Therapeutics, Inc.1.55MUS$52M0.25%
Monte Rosa Therapeutics, Inc.4.35MUS$51.8M0.25%
Relay Therapeutics, Inc.2.83MUS$51M0.24%
Ionis Pharmaceuticals, Inc.1.02MUS$45.7M0.22%
Structure Therapeutics, Inc.1.43MUS$44.8M0.21%
Enliven Therapeutics, Inc.905KUS$41.5M0.20%
Bicycle Therapeutics PLC10.9MUS$40.1M0.19%
Prelude Therapeutics Incorporated10.1MUS$39.6M0.19%
Mirum Pharmaceuticals, Inc.446KUS$38.1M0.18%
Design Therapeutics, Inc.2.99MUS$37.6M0.18%
Stoke Therapeutics, Inc.1.31MUS$34.2M0.16%
Entrada Therapeutics, Inc.5.07MUS$32.2M0.15%
Neurogene Inc.992KUS$27.6M0.13%
Xencor, Inc.1.1MUS$27.5M0.13%
Sensei Biotherapeutics, Inc.803KUS$23.9M0.11%
Absci Corporation2.13MUS$23M0.11%
Disc Medicine, Inc.350KUS$22.9M0.11%
Arcus Biosciences, Inc.845KUS$21.8M0.10%
Generate Biomedicines, Inc.1.42MUS$21.4M0.10%
Taysha Gene Therapies, Inc.4MUS$19.5M0.09%
Aktis Oncology, Inc.996KUS$19.4M0.09%
Jade Biosciences, Inc.1.23MUS$17.3M0.08%
DBV Technologies SA1.46MUS$17.2M0.08%
First Tracks Biotherapeutics, Inc.473KUS$16.8M0.08%
Parabilis Medicines, Inc.500KUS$16.1M0.08%
Tectonic Therapeutic, Inc.608KUS$14.2M0.07%
Cytokinetics, Incorporated211KUS$13.9M0.07%
Xenon Pharmaceuticals Inc.370KUS$13.8M0.07%
CytomX Therapeutics, Inc.4.98MUS$13.5M0.06%
Dyne Therapeutics, Inc.813KUS$13.1M0.06%
Scribe Therapeutics Inc.689KUS$12.7M0.06%
Freenome, Inc.795KUS$12.5M0.06%
MapLight Therapeutics, Inc.1.17MUS$11.9M0.06%
BioNTech SE120KUS$11.8M0.06%
Sera Prognostics, Inc.5.5MUS$11.5M0.05%
Evommune, Inc.1.23MUS$10.2M0.05%
Intellia Therapeutics, Inc.829KUS$10M0.05%
Avalyn Pharma Inc.350KUS$9.97M0.05%
Avalo Therapeutics, Inc.550KUS$8.43M0.04%
Tango Therapeutics, Inc.333KUS$8.32M0.04%
LB Pharmaceuticals Inc200KUS$7.68M0.04%
Protara Therapeutics, Inc.1.84MUS$5.62M0.03%
Cerus Corporation2.33MUS$5.55M0.03%
vTv Therapeutics Inc.148KUS$4.57M0.02%
Q32 Bio Inc.548KUS$4.53M0.02%
Eikon Therapeutics, Inc.556KUS$4.47M0.02%
Immunome, Inc.55,306US$1.19M<0.01%
Sana Biotechnology, Inc.310KUS$905K<0.01%
TScan Therapeutics, Inc.2.78MUS$876K<0.01%
Aligos Therapeutics, Inc.83,055US$468K<0.01%
Tyra Biosciences, Inc.10,607US$232K<0.01%
Alumis Inc.0US$00.00%
Crinetics Pharmaceuticals, Inc.0US$00.00%
Sagimet Biosciences Inc. - Series A0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%
Skye Bioscience, Inc.0US$00.00%
Verastem, Inc.0US$00.00%
Viridian Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related